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Abstract 
Europe, because of its geographic location, strategic position on trade routes and colonial past 
has a long history in caring for travellers’ health. Within Europe, there is great diversity in the 
practice of travel medicine. Some countries have travel medicine societies and a periodic 
distribution of recommendations but many countries have no national, pre-travel guidelines 
and follow international recommendations such as those provided by World Health 
Organisation. Providers of travel medicine include tropical medical specialists, general 
practice nurses and physicians, specialist “travel clinics”, occupational physicians and 
pharmacists. One of the core functions of the ECDC funded network of travel and tropical 
medicine, EuroTravNet, is to document the status quo of travel medicine in Europe. A three 
prong approach is used with a real-time online questionnaire, a structured interview with 
experts in each country and web searching.  
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Introduction 
Europe, because of its geographic location, strategic position on trade routes and colonial 
history has a long history in caring for travellers’ health. “Quarantine” (Ital. quaranta giorne, 
forty days) was invented in Italy (1) and this precaution against travel-associated disease was 
practised widely in the ports of fourteenth century Europe (1348 Venice, 1377 Ragusa and 
1383 Marseille). Disease is not one-way and traveller mobility can lead to morbidity in both 
the source and receiving countries. Europeans have been stricken by imported diseases that 
spread rapidly through Europe, such as the 14th century Black Death (plague) which 
originated in Asia and the 16th century syphilis epidemic which came from America (put 
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possibily originated in Europe).  On the other hand, Europeans have exported and spread 
diseases such as measles and smallpox (2-4). In the last century, the health of the colonial 
traveller assumed great importance. The Livingstone exhibition in London  (January 1900) 
was an extravagant array of travel medicine “commodities” and pre-travel advice to help 
travellers maintain health and hygiene in the deadly “tropics” (5). The Burroughs Wellcome 
& Co. (BWC) displayed their hugely successful “Tabloid medical chest” (figure 1) which 
contained essential travel medicines in innovative tablet form (as opposed to old-fashioned 
powders) that could be used for “the air, for the earth, for the depths, and for every clime 
under every condition”. Returning ill travellers were treated at European tropical medicine 
schools and hospitals (6) that specialised in diseases of the “tropics” such as malaria (also 
endemic in parts of Europe at that time) and filariasis and in 1889 Sir Patrick Manson 
published his “Manual of Tropical Disease” (7).  In the 20th century, with increasing ease of 
travel, the need to provide medical care for travellers, both before and after travel, increased 
exponentially. Business and leisure travel in Europe became part of a “desirable lifestyle” and 
was facilitated by the proliferation of low cost airline travel. High rates of immigration into 
Europe led to intermingled populations with a strong demand for visits to friends and relatives 
(VFR travel). The World Health Organisation publishes an annual volume “International 
Travel and Health” which is addressed to meet the needs of national health administrations, 
practising travel health advisors, tourist agencies, shipping companies, airline operators and 
all who are called on to give health advice to travellers (www.who.int/ith). The revised  
International Health Regulations (IHR)(8) came into force with the aim of helping the 
international community to prevent and respond to acute public health risks that have the 
potential to cross borders and threaten international health. New health risks such as the novel 
H5N1 avian influenza and the pandemic H1N1 influenza virus have enormous implications 
for travel and public health.  
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Today, in the 21st century, travel is faster and easier. To travel around the world takes 36 
hours rather than the fanciful 80 days of Jules Verne’s Europe in 1873 (9). There are several 
players in travel medicine including general practice health professionals, national and 
international authorities, occupational health advisors and the travel industry itself (10). 
Travel health is an increasingly complex speciality and encompasses the identification and 
epidemiology of travel–associated disorders and diseases and their geographical distribution 
(11), the pre-travel, prevention of these conditions through education, vaccination, 
chemoprophylaxis, self-treatment (for certain conditions) and finally the care of the ill-
returned traveller or the newly arrived migrant or refugee. Disease surveillance is of 
increasing importance and two networks, EuroTravNet (www.eurotravnet.eu) and 
TropNetEurop (www.tropnet.net) monitor the epidemiology of travel associated illness in 
Europe. In this post-colonial era, migration medicine is an integral part of travel medicine and 
several European institutions have particular expertise in migration medicine.  
Travel within, from and to Europe  
Europe is the worldwide continental leader in outbound trip volume and international tourism 
expenditure (12). Germany generates the most travel associated spending, 59 billion euros in 
2006 compared to the US (57 billion), and the UK (50 billion). Other Europeans in the top ten 
spenders ranking were France, Italy and the Russian Federation. In 2006, a total of 475 
million Europeans travelled internationally (402.1 million in Europe, 24 million to the 
Americas, 21.2 million to Asia and the Pacific, 16.8 million to Africa and 11.2 million to the 
Middle East). In 2006, more than 462 million arrivals were registered in Europe, 53% were 
travelling for leisure, 17% for business and importantly, more than 30% were in the category 
VFR (visiting friends and relatives). Travel within Europe has many implications for health. 
Over 23 million Germans visit the Mediterranean area each year with risks such as diarrhoea, 
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hepatitis A, papataci fever, echinococcosis and  leishmaniasis and visitors to Northern and 
Central Europe have a risk of tick-borne encephalitis . 
 
Profile of travel associated illness in European travellers travelling to tropical areas 
The epidemiology of travel-related infectious diseases in over 17,000 ill 
returned European travellers presenting to EuroTravNet/GeoSentinel sites 
from 1997-2007 has recently been published (13). Gastrointestinal illness (particularly for 
tourists), fever (seen in those visiting friends and relatives; VFRs) and skin disorders (in 
tourists) were the most common reasons for presentation in European travellers. Diagnoses 
varied by region visited. This regional distribution was most pronounced for acute diarrhoea, 
and other diagnoses including Campylobacter spp, Shigella spp, giardia, amoebas, malaria, 
dengue, Chikungunya, rickettsioses, salmonellosis animal-related injuries requiring 
rabies post exposure prophylaxis (PEP), larva migrans, leishmaniasis, 
myasis, respiratory syndromes, genitourinary and sexually transmitted 
diseases, schistosomiasis and cerebro-meningeal infections. Diagnoses also 
varied by country of origin and categories of travellers. Ill VFRs who 
returned from sub-Saharan Africa and Indian Ocean Islands (AIOI), were by 
far more likely to experience falciparum malaria than any other group. 
Interestingly, significant odds ratios were observed for European versus 
non-European travellers in the likelihood of acquiring certain 
travel-associated infectious diseases were noted. Immigrant-travellers account for a large 
proportion of patients. Fever is the main presenting symptom for European immigrants. 
Significant odds ratios for dengue, malaria, salmonellas, genito-urinary diseases, respiratory 
disorders, dermatological diagnoses, were observed for European versus non-European 
travellers. European travellers differ from travellers outside Europe mainly because of the 
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characteristics of their immigrant communities, many originating in sub-Saharan Africa. 
Physicians in Europe who provide pre-travel advice and who care for returned travellers need to 
be aware of the expected profile of travel-associated illness in Europe.  
 
Why is ECDC interested in travel medicine? 
Travel medicine is an emerging specialty. It includes a wide range of aspects of disease 
related to travel. Many of these activities are outside of ECDC’s scope, but others concerned 
not only with prevention of infectious diseases during travel but also with risk assessment of 
imported infectious threats are related to its mission. According to the Article 3 of its 
founding Regulation, ECDC's mission is to identify, assess and communicate current and 
emerging threats to human health posed by infectious diseases. (14). The  ECDC experience 
has shown that many of these threats are related to human mobility.(15)  
Travel health clinics providing up to date advice on risk and risk reduction can be effective in 
preventing disease (16) and even cost-effective (17). However, the epidemiology of infectious 
disease risks to the traveller changes rapidly and continuously; (18) those giving travel health 
advice need to ensure access to up-to-date authoritative sources of advice and 
recommendations. Many countries and organizations, including EU member states and the 
WHO (http://www.who.int/ith/en/), produce such recommendations, some of them are 
reliable, but others are out-dated. There are several institutions in the EU and outside EU 
dealing with travel medicine and it is important for ECDC to evaluate the possible added 
value of being involved in the field. To identify gaps in the practice of European travel 
medicine in which ECDC could play a role, a global picture of community expertise, 
structures and agencies already issuing advice, as well as an evaluation of the accuracy and 
usefulness of the information provided should be taken into account in order to avoid 
duplication of effort (Article 6 of ECDC’s founding Regulation).(14) 
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Some roles for ECDC in this field have already been identified. Imported communicable 
diseases pose a threat not only to Europeans travelling abroad, but also to persons exposed to 
returned travellers who carry contagious disease. Secondary cases of many imported 
infections in Europe are rare given the absence of essential vectors in the life cycle of 
organisms and good sanitary conditions, but new circumstances such as the introduction of 
vectors, migratory waves and intensified international travel make onward transmission of 
imported infections more likely. A good example of how an imported case can lead to a 
generalized outbreak was the autochthonous transmission of chikungunya virus in Italy in 
August 2007(18). The presence of Aedes albopictus in Europe (19) highlights the need for 
continuous awareness for dengue and chikungunya virus infection, as imported cases may 
result in secondary cases occurring in the European Union. ECDC monitoring these and other 
travel related health threats and may need advice and guidance for risk assessment and risk 
communication from tropical and travel medicine experts to improve assessment and response 
(15). The SARS outbreak in 2003 illustrated how quickly a new virus could spread 
internationally in the modern age.(20)  This was one of the reasons why the EU decided to 
establish ECDC: to help strengthen Europe’s defences against future disease outbreaks which 
are a constant threat for vulnerable and for many diseases immunologically naive European 
population.(14) 
To fulfil these tasks, ECDC has established collaboration through a public tender with 
Eurotravnet (www.eurotravnet.eu), a travel medicine network of travel health experts, which 
supports ECDC providing expert advice for the detection, verification, assessment and 
communication of communicable diseases that can be associated with travelling and 
specifically with tropical diseases 
(http://ecdc.europa.eu/en/aboutus/calls/Lists/Calls%20for%20tender/ECDC_DispForm.aspx?
List=a70e951a%2D9260%2D4909%2Dbc27%2Dcefd2af6e9a4&ID=301&RootFolder=%2Fe
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n%2Faboutus%2Fcalls%2FLists%2FCalls%20for%20tender) and will establish a European 
inventory of travel medicine providers and resources in EU, EFTA and candidate states (21) 
 
How EuroTravNet aims to document the “status quo” of travel medicine in Europe  
In this, the first year of EuroTravNet, one of the primary goals is to set up an European 
inventory of travel medicine providers and resources. 
  
A systematic three-prong approach is used : 
1. Real-time data are collated with an on-line, internet based questionnaire (22) (this 
questionnaire  has 10 questions) and entered into a database..The questionnaire is available at 
http://www.surveymonkey.com/s.aspx?sm=t3HkKAnexJxKme6ap7GBUg_3d_3d .  
 
In brief, the questionnaire provides data on demographics, the type of travel medicine 
practice/institution, the variety of travel health services provided (pre/post travel, yellow fever 
vaccination etc), the profile of travellers seen, the numbers of travellers seen prior to or after 
travel, the number of yellow fever vaccinations administered, specific health sevices that are 
offered for migrants, the research and publication track record of individuals and centres. The 
questionnaire has been distributed at conferences (including the ISTM conference in Budapest 
in May 2009) and there is an active collation of e-mail addresses for travel medicine advisors 
in individual countries using web sites, yellow fever vaccinating centres, personal contacts, 
ISTM listings and a publication in Eurosurveillance 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19245. 
By the end of 2009, it is hoped to have a broad coverage of travel medicine providers in 
Europe. All EU, EFTA and candidate states have individuals who have answered the survey. 
Those countries with low responses are actively followed up and participation from the new 
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EU members and candidate states is especially important as few data are available on travel 
medicine in these countries. This method is real time and has proven ideal to provide data on 
all types of travel medicine practitioners. Respondents can update their data and all health 
professionals including tropical medicine specialists, nurses, physicians, pharmacists and 
scientists involved in travel medicine can be included. In the future, this ECDC resource 
listing will be a centre for dissemination of information relating to travel medicine, for 
networking of centres with similar interests and to identify European institutions with 
particular expertise in migrant health. The contents of the database are not available to third 
parties and all data collected belong to ECDC. To date, over 900 Europeans have completed 
some or all of the questionnaire and a preliminary analysis will be reported in January 2010. 
 
2. A second tool used is the « structured interview » (see Box 1) to enable the creation of a 
concise document detailing the status quo of travel medicine in member and allied states. The 
structured phone interview consists of 11 questions and is designed to provide a national 
picture for each of the European countries. One or two national experts in each country are 
approached and asked to provide answers to the 11 questions in the box below. The questions 
are distributed in advance to the experts and they are free to respond by email or phone. 
  
3. Finally, web searching is used to compile tables of topics and websites relating to travel 
medicine (Tables 1 and 2). Identification of topics and websites relating to travel medicine 
with a focus on Europe and an overview of global resources. 
 
The landscape of travel medicine in Europe 
Within Europe, there is great diversity in the practice of travel medicine. Some countries have 
travel medicine societies and an efficient distribution of recommendations. Many countries 
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have no national, pre-travel guidelines and follow international recommendations such as 
those provided by WHO or CDC. Providers of travel medicine include tropical medical 
specialists, general practice nurses and physicians, specialist “travel clinics”, occupational 
physicians and pharmacists. There is currently a dearth of guidelines regarding the required 
qualification to practice travel medicine and whether no not certification is needed. Each 
country has a distinct provider type profile and there is also variation as to whether travel 
medicine (both pre-and post-travel) is provided in the private or public sector. The provision 
of the yellow fever vaccine is usually regulated by national or regional health authorities in 
each of the member states and in the UK; there is formal program of registration, training, 
standard and audit for yellow fever vaccination centres (23).  
 
Conclusions 
Diversity of travel medicine practice in Europe is not ,per se, negative and harmonisation of 
guidelines is not necessarily the ultimate goal. There is, however, great potential in Europe to 
find common ground in travel medicine practice, to establish evidence-based advice, to 
optimise practice by learning from neighbour states as each country has a different type of 
expertise. This first tentative step, a collaboration between ISTM, ECDC and EuroTravNet 
aiming to define the current situation of travel medicine in EU and allied countries, may 
become a giant leap forward for travel medicine in Europe.  
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FIGURE 1 
“Tabloid first aid” – Burroughs Welcome’s Tabloid medicine chest (Welcome Library, 
London) 
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Table 1. Travel Medicine Websites in EU countries  
Austria www.reisemed.at/ 
 
Belgium http://www.itg.be/ITG/GeneralSite/Ge
neralPage.asp?Page=Medische+Diens
ten+%2D+Reisgeneeskunde&HT=Me
dische+Diensten&ST=Reisgeneeskun
de 
 
Bulgaria http://74.125.43.132/translate_c?hl=d
e&sl=bg&u=http://www.ncipd.org/&p
rev=/search%3Fq%3Dministry%2Bof
%2Bhealth%2Bbulgaria%26hl%3Dde
%26client%3Dsafari%26rls%3Dde-
de&rurl=translate.google.com&usg=
ALkJrhivxwzLqTKPtOFkmQv8456b
vOUuiA 
 
Croatia http://www.mzss.hr/hr 
 
Cyprus                - 
Czech 
Republic 
http://www.mzcr.cz/Verejne/Default.a
spx 
 
Czech  
Republic 
http://www.e-
globals.net/web/ordinace/eng/info_ces
tovatele.asp 
 
Denmark http://www.ssi.dk/sw162.asp 
 
Estonia http://translate.google.com/translate?h
l=de&sl=et&u=http://www.tervisekait
se.ee/&ei=N3pcSpOZCceMjAfDgIHj
DQ&sa=X&oi=translate&resnum=1&
ct=result&prev=/search%3Fq%3Dest
onian%2Bhealth%2Bprotection%2Bi
nspectorate%26hl%3Dde%26client%
3Dsafari%26rls%3Dde-de 
 
  
France http://www.diplomatie.fr/voyageurs/et
rangers/avis/conseils/cartlst.asp 
France http://www.invs.sante.fr/beh/2002/24/
IVS_BEH24.pdf 
France http://www.astrium.com/ 
 
Macedonia http://www.iph.mk/ 
 
Germany www.dtg.de 
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Germany www.dtg.de 
www.crm.de   
Greece www.keel.org.gr/ 
 
Hungary www.antsz.hu/ 
 
Iceland www.landlaeknir.is/ 
 
Ireland http://tmb.exodus.ie/latest.asp 
 
http://foreignaffairs.gov.ie/home/inde
x.aspx?id=275  
Italy www.ministerosalute.it/malattieInfetti
ve/paginaMenuMalattieInfettive.jsp?
menu=viaggiatori&lingua=italiano 
 
Latvia http://www.lic.gov.lv/index.php?p=11
51&pp=464&lang=259 
 
Lithuania http://www.ulpkc.lt/tekstai/profilaktik
a/keliautojams%20rekomendacijos%2
02009.pdf 
 
http://www.ulpkc.lt/ulpkc.imuno.php 
 
 
Luxembourg http://www.sante.public.lu/fr/rester-
bonne-sante/voyages/index.html 
 
Malta www.health.gov.mt/publications/inde
x.htm 
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Netherlands www.lcr.nl/ 
 
Norway http://www.fhi.no/eway/default.aspx?
pid=233&trg=MainArea_5661&Main
Area_5661=5631:0:15,2386:1:0:0:::0:
0 
 
Poland http://www.biuletyn.abip.pl/ucmmit/ 
 
Portugal http://www.ihmt.unl.pt/ConsultadoVia
jante/consulta.asp 
 
Romania http://www.ispb.ro/ 
 
Slovakia http://www.fitcom.sk/ 
 
Slovenia http://www.ivz.si/ 
 
Spain http://www.msc.es/en/ciudadanos/prot
eccionSalud/vacunaciones/docs/recoV
acunasAdultos.pdf 
 
http://www.msc.es/en/ciudadanos/prot
eccionSalud/vacunaciones/viajero/ho
me.htm 
 
Sweden www.vaccination.nu/ 
http://1177.se/start.asp 
 
Switzerland http://www.bag.admin.ch/infekt/publ/
bulletin/d/reisemed%20bu42.pdf 
Turkey  
United 
Kingdom 
http://www.doh.gov.uk/traveladvice/ 
 
United 
Kingdom 
http://www.doh.gov.uk/traveladvice/ta
bles.htm 
 
http://www.fitfortravel.scot.nhs.uk/ho
me.aspx 
 
http://www.travelhealth.co.uk/ 
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Table 2. Travel Medicine websites of global interest 
 
TRAVAX In english Subscription 
needed 
http://www.travax.scot.nhs.uk/ 
 
Tropimed In English, French 
and German 
Subscription 
needed 
http://www.astral.ch/ALL/tropimed.ht
m 
ISTM International 
Society of Travel 
Medicine 
Parts of the website 
are for members 
only 
www.istm.org 
MASTA MASTA, Medical 
Advisory Service 
for travellers 
Subscription 
needed 
http://www.masta.org/ 
 
Worldwise New Zealand travel 
health 
 www.worldwise.co.nz) 
Travel Health  
Online 
(Shoreland) 
In English  http://www.tripprep.com/ 
 
Travellers 
Medical 
&Vaccination 
Center 
Australian travel 
health advice 
 http://www.tmvc.com.au/ 
 
National 
Travel Health 
Network and 
Centre 
 
NaTHNaC 
Yellow Fever 
Vaccination 
Centres in the UK 
 www.nathnac.org/travel/factsheets/YF
.htm 
 
 
 
WHO International travel 
and Health 
 http://www.who.int/ith/en/index.html 
 
CDC Centre for Disease 
Control and 
Prevention 
 
 http://wwwn.cdc.gov/travel/default.as
px 
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Structured Interview 
 
1. Who are the main practitioners of travel medicine in your country? Please assign a 
proportion (%) 
- GPs 
-Specialised travel clinics 
-Nurse travel medicine advisors 
-Occupational medicine physicians in companies/institutions (army etc) 
-pharmacists 
-infectious disease specialists 
-clinics attached to academic institutions 
-Other? 
2. Is there a society of travel medicine in your country? If yes, what is its composition? No. of 
members? 
3. Does this society provide guidelines on travel medicine? Website? 
4. If yes, how are these guidelines distributed and how often are they updated? 
5. If no, do travel medicine practitioners follow WHO guidelines or other? 
6. Is there a central body in charge of yellow fever vaccinating individuals or sites? 
7. Are there special requirements including training required for yellow fever vaccination 
sites? 
8. Are there centres in your country with expertise in migration medicine ? 
9. What do you see as major deficit areas in travel medicine in your country? 
10. Do you have ideas as to how travel medicine practice could be improved in your country? 
11. Do you think accreditation in travel medicine is necessary? In what form? Certificate in 
Travel Medicine? 
 
 
 
